Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,852,356 papers from all fields of science
Search
Sign In
Create Free Account
coxsackievirus A21
Known as:
CVA21
A naturally occurring enterovirus with potential antitumor activity. Upon intratumoral administration, coxsackievirus A21 targets and binds to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Coxsackievirus A21 Ab:ACnc:Pt:Ser:Qn
Coxsackievirus A21 Ab:Titr:Pt:Ser:Qn
Coxsackievirus A21 Ab:Titr:Pt:Ser:Qn:Comp fix
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract CT026: Phase 1b study of intratumoral Coxsackievirus A21 (CVA21) and systemicpembrolizumab inadvanced melanoma patients: Interim results of the CAPRA clinical trial
A. Silk
,
H. Kaufman
,
+8 authors
A. Zloza
2017
Corpus ID: 79627275
Background: Coxsackievirus A21 (CVA21) is a novel bio-selected oncolytic, immunotherapeutic agent. Intratumoral (i.t.) CVA21…
Expand
2017
2017
Abstract CT115: Phase 1bKEYNOTE 200 (STORM study):A study of an intravenously delivered oncolytic virus, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients
H. Pandha
,
K. Harrington
,
+10 authors
D. Shafren
2017
Corpus ID: 79634592
Background: Coxsackievirus A21 (CVA21, CAVATAK) is a naturally occurring ICAM-1 targeted oncolytic immunotherapeutic virus…
Expand
2012
2012
590 Final Results of a Phase Ib Study of CUDC-101, a Multitargeted Inhibitor of EGFR, HER2, and HDAC, in Patients with Advanced Head and Neck, Gastric, Breast, Liver, and Non-small Cell Lung Cancer
M. Voi
,
S. Fu
,
+7 authors
R. Laliberté
2012
Corpus ID: 71288563
2005
2005
A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
M. Roivainen
,
N. Alakulppi
,
+4 authors
T. Hovi
Journal of Virological Methods
2005
Corpus ID: 39848114
Highly Cited
2004
Highly Cited
2004
Gaining target access for deoxyribozymes.
S. Schubert
,
J. Fürste
,
+4 authors
J. Kurreck
Journal of Molecular Biology
2004
Corpus ID: 2779665
1998
1998
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.
D. Shafren
,
D. Dorahy
,
R. Thorne
,
T. Kinoshita
,
R. D. Barry
,
G. Burns
Journal of Immunology
1998
Corpus ID: 26036255
Decay-accelerating factor (DAF), a widely expressed membrane complement-regulatory protein, is utilized as a cellular receptor by…
Expand
1991
1991
The nucleotide sequence of 3C proteinase region of the coxsackievirus A24 variant: Comparison of the isolates in Taiwan in 1985–1988
Kuei-Hsiang Lin
,
N. Takeda
,
K. Miyamura
,
S. Yamazaki
,
Chen-Wu Chen
Virus genes
1991
Corpus ID: 24471782
Acute hemorrhagic conjunctivitis caused by coxsackievirus A24 variant (CA24v) first appeared in Taiwan in October 1985, followed…
Expand
1989
1989
Detection of enteroviruses using cDNA and synthetic oligonucleotide probes
C. Bruce
,
W. Al-nakib
,
M. Forsyth
,
G. Stanway
,
J. W. Almond
Journal of Virological Methods
1989
Corpus ID: 36391494
1987
1987
Nucleic acid sequence relationships between enterovirus serotypes.
T. Hyypiä
,
M. Maaronen
,
+7 authors
M. Stenvik
Molecular and Cellular Probes
1987
Corpus ID: 33026661
1985
1985
Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses.
E. Emini
,
W. Schleif
,
R J Colonno
,
Eckard Wimmer
Virology
1985
Corpus ID: 20539581
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE